FDA Renews Charter for Antimicrobial Drugs Advisory Committee
January 09, 2025
January 09, 2025
WASHINGTON, Jan. 9 (TNSFR) -- The Food and Drug Administration (FDA) has announced the renewal of the Antimicrobial Drugs Advisory Committee's charter, extending its authority until October 7, 2026.
This decision reflects the agency's commitment to ensuring public health through expert guidance on the safety and effectiveness of drugs used to treat infectious diseases. The committee, which comprises 13 voting members, offers recommendations on marketed and investigational . . .
This decision reflects the agency's commitment to ensuring public health through expert guidance on the safety and effectiveness of drugs used to treat infectious diseases. The committee, which comprises 13 voting members, offers recommendations on marketed and investigational . . .